NCI ‘Last Mile’ Initiative Innovates Self-Sampling for HPV Screening
New self-sampling technologies screening for HPV could help increase access and reduce cervical cancer among underserved and high-burden populations.
The National Cancer Institute’s Last Mile initiative is exploring new ways at getting screening tests for cervical cancer into more hands. Women who die from cervical cancer often have had limited or no access to screenings. This is just one element that has largely driven the White House’s Cancer Moonshot Program to significantly reduce the death rate from cancer over the coming years.
Dr. Vikrant Sahasrabuddhe, deputy chief of the Breast and Gynecologic Cancer Research Group and Program Director in the Division of Cancer Prevention at NCI, discusses more about how technology and research are driving the Last Mile initiative and how it is reducing health inequities by reaching women where they are with more at-home screening options. Sahasrabuddhe also highlights how advancements with tools like AI are improving diagnosing and treating cervical cancer.
-
Dr. Vikrant Sahasrabuddhe Program Director, Division of Cancer Prevention NCI
-
NCI Uses Wearables Data to Link Exercise to Cancer Risk
NCI finds a connection between low-intensity exercise and decreased risk of cancer through data collected from wearable technology.
9m listen -
Space Force’s Former CITO Talks AI Dominance Amid Rising Global Competition
Lisa Costa explains how the Trump administration’s recent AI legislation has signaled a strategic shift toward more agile and collaborative federal AI development.
9m listen -
How AI and Data Are Shaping the Future of the Coast Guard
Deputy CIO Brian Campo says USCG is focusing its AI on efficiency, learning from peers and simplifying regulations for the maritime community.
17m watch -
NCI's Tech-Based Therapy Helps Patients Battle HPV-Linked Respiratory Disease
A new tech-based therapy is helping NCI treat patients who suffer from a respiratory illness associated with HPV.
23m listen
